The DNA damage response network in the treatment of head and neck squamous cell carcinoma
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The DNA damage response network in the treatment of head and neck squamous cell carcinoma
Authors
Keywords
-
Journal
ESMO Open
Volume 6, Issue 2, Pages 100075
Publisher
Elsevier BV
Online
2021-03-11
DOI
10.1016/j.esmoop.2021.100075
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oxaliplatin-DNA Adducts as Predictive Biomarkers of FOLFOX Response in Colorectal Cancer: A Potential Treatment Optimization Strategy
- (2020) Maike Zimmermann et al. MOLECULAR CANCER THERAPEUTICS
- Monitoring DNA Damage and Repair in Peripheral Blood Mononuclear Cells of Lung Cancer Radiotherapy Patients
- (2020) Pavel N. Lobachevsky et al. Cancers
- Long-term Survival in Head and Neck Cancer: Impact of Site, Stage, Smoking, and Human Papillomavirus Status
- (2019) Eugenie Du et al. LARYNGOSCOPE
- Keynote-365 cohort a: Pembrolizumab (pembro) plus olaparib in docetaxel-pretreated patients (pts) with metastatic castrate-resistant prostate cancer (mCRPC).
- (2019) Evan Y. Yu et al. JOURNAL OF CLINICAL ONCOLOGY
- DNA damage accumulation, defective chromatin organization and deficient DNA repair capacity in patients with rheumatoid arthritis
- (2019) Vassilis L. Souliotis et al. CLINICAL IMMUNOLOGY
- Inhibition of ATM increases interferon signaling and sensitizes pancreatic cancer to immune checkpoint blockade therapy
- (2019) Qiang Zhang et al. CANCER RESEARCH
- Open-label, multicenter, phase I study to assess safety and tolerability of adavosertib plus durvalumab in patients with advanced solid tumors.
- (2019) Manish R. Patel et al. JOURNAL OF CLINICAL ONCOLOGY
- Polymorphisms of Mismatch Repair Pathway Genes Predict Clinical Outcomes in Oral Squamous Cell Carcinoma Patients Receiving Adjuvant Concurrent Chemoradiotherapy
- (2019) Thomas Senghore et al. Cancers
- A decade of clinical development of PARP inhibitors in perspective
- (2019) J Mateo et al. ANNALS OF ONCOLOGY
- DNA sensing by the cGAS–STING pathway in health and disease
- (2019) Mona Motwani et al. NATURE REVIEWS GENETICS
- Diagnostic Tumor Markers in Head and Neck Squamous Cell Carcinoma (HNSCC) in the Clinical Setting
- (2019) Panagiota Economopoulou et al. Frontiers in Oncology
- Could excision repair cross‐complementing group‐1 mRNA expression from peripheral blood lymphocytes predict locoregional failure with cisplatin chemoradiation for locally advanced laryngeal cancer?
- (2019) Vijay Parshuram Raturi et al. Asia-Pacific Journal of Clinical Oncology
- Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4
- (2019) Shuang Qin et al. Molecular Cancer
- DNA Damage Response and Oxidative Stress in Systemic Autoimmunity
- (2019) Vassilis L. Souliotis et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Cytosolic DNA-Sensing cGAS–STING Pathway in Cancer
- (2019) John Kwon et al. Cancer Discovery
- An open-label, phase II basket study of olaparib and durvalumab (MEDIOLA): Results in germline BRCA -mutated ( gBRCA m) platinum-sensitive relapsed (PSR) ovarian cancer (OC)
- (2018) Y. Drew et al. GYNECOLOGIC ONCOLOGY
- A phase 1b study of the anti-PD-1 monoclonal antibody BGB-A317 (A317) in combination with the PARP inhibitor BGB-290 (290) in advanced solid tumors.
- (2018) Michael Friedlander et al. JOURNAL OF CLINICAL ONCOLOGY
- The cGAS–cGAMP–STING pathway connects DNA damage to inflammation, senescence, and cancer
- (2018) Tuo Li et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The prognostic value of basal DNA damage level in peripheral blood lymphocytes of patients affected by bladder cancer
- (2018) Alessandra Allione et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Increased oxidative stress mediates the antitumor effect of PARP inhibition in ovarian cancer
- (2018) Dong Hou et al. Redox Biology
- TOPACIO/Keynote-162: Niraparib + pembrolizumab in patients (pts) with metastatic triple-negative breast cancer (TNBC), a phase 2 trial.
- (2018) Shaveta Vinayak et al. JOURNAL OF CLINICAL ONCOLOGY
- ROS and the DNA damage response in cancer
- (2018) Upadhyayula Sai Srinivas et al. Redox Biology
- Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations
- (2018) Fatima Karzai et al. Journal for ImmunoTherapy of Cancer
- Apoptotic capacity and risk of squamous cell carcinoma of the head and neck
- (2017) Zhensheng Liu et al. EUROPEAN JOURNAL OF CANCER
- Safety and Clinical Activity of the Programmed Death-Ligand 1 Inhibitor Durvalumab in Combination With Poly (ADP-Ribose) Polymerase Inhibitor Olaparib or Vascular Endothelial Growth Factor Receptor 1-3 Inhibitor Cediranib in Women's Cancers: A Dose-Escalation, Phase I Study
- (2017) Jung-Min Lee et al. JOURNAL OF CLINICAL ONCOLOGY
- Association of DNA repair genes polymorphisms and mutations with increased risk of head and neck cancer: a review
- (2017) Agata Dylawerska et al. MEDICAL ONCOLOGY
- The multifaceted roles of PARP1 in DNA repair and chromatin remodelling
- (2017) Arnab Ray Chaudhuri et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Basal oxidative stress ratio of head and neck squamous cell carcinomas correlates with nodal metastatic spread in patients under therapy
- (2017) Didier Dequanter et al. OncoTargets and Therapy
- DNA Damage and Repair Biomarkers of Immunotherapy Response
- (2017) Kent W. Mouw et al. Cancer Discovery
- Genomic and Epigenomic Alterations in Cancer
- (2016) Balabhadrapatruni V.S.K. Chakravarthi et al. AMERICAN JOURNAL OF PATHOLOGY
- DNA repair of myeloma plasma cells correlates with clinical outcome: the effect of the nonhomologous end-joining inhibitor SCR7
- (2016) M. Gkotzamanidou et al. BLOOD
- RECIST 1.1—Update and clarification: From the RECIST committee
- (2016) Lawrence H. Schwartz et al. EUROPEAN JOURNAL OF CANCER
- Cell cycle checkpoint in cancer: a therapeutically targetable double-edged sword
- (2016) Roberta Visconti et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Regulation and function of the cGAS–STING pathway of cytosolic DNA sensing
- (2016) Qi Chen et al. NATURE IMMUNOLOGY
- Repair Pathway Choices and Consequences at the Double-Strand Break
- (2016) Raphael Ceccaldi et al. TRENDS IN CELL BIOLOGY
- Classical non-homologous end-joining pathway utilizes nascent RNA for error-free double-strand break repair of transcribed genes
- (2016) Anirban Chakraborty et al. Nature Communications
- The DNA damage response and immune signaling alliance: Is it good or bad? Nature decides when and where
- (2015) Ioannis S. Pateras et al. PHARMACOLOGY & THERAPEUTICS
- Aberrant DNA Damage Response Pathways May Predict the Outcome of Platinum Chemotherapy in Ovarian Cancer
- (2015) Dimitra T. Stefanou et al. PLoS One
- DNA repair deficiency in peripheral blood lymphocytes of endometrial cancer patients with a family history of cancer
- (2014) Lyubov Buchynska et al. BMC CANCER
- Chromatin structure, transcriptional activity and DNA repair efficiency affect the outcome of chemotherapy in multiple myeloma
- (2014) M Gkotzamanidou et al. BRITISH JOURNAL OF CANCER
- Combined effect of tobacco and DNA repair genes polymorphisms of XRCC1 and XRCC2 influence high risk of head and neck squamous cell carcinoma in northeast Indian population
- (2014) Javed Hussain Choudhury et al. MEDICAL ONCOLOGY
- Deregulation of base excision repair gene expression and enhanced proliferation in head and neck squamous cell carcinoma
- (2014) Ishrat Mahjabeen et al. TUMOR BIOLOGY
- Apoptosis and Molecular Targeting Therapy in Cancer
- (2014) Mohamed Hassan et al. Biomed Research International
- The causes and consequences of genetic heterogeneity in cancer evolution
- (2013) Rebecca A. Burrell et al. NATURE
- DNA crosslinks, DNA damage and repair in peripheral blood lymphocytes of non-small cell lung cancer patients treated with platinum derivatives
- (2013) PETRA FIKROVA et al. ONCOLOGY REPORTS
- Nucleotide Excision Repair in Eukaryotes
- (2013) O. D. Scharer Cold Spring Harbor Perspectives in Biology
- DNA repair gene expression level in peripheral blood and tumour tissue from non-small cell lung cancer and head and neck squamous cell cancer patients
- (2012) Marina Schena et al. DNA REPAIR
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Micronucleus frequencies in lymphocytes and buccal epithelial cells from patients having head and neck cancer and their first-degree relatives
- (2011) S. Burgaz et al. MUTAGENESIS
- Impaired nucleotide excision repair pathway as a possible factor in pathogenesis of head and neck cancer
- (2011) T. Sliwinski et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- Homologous recombination in cancer development, treatment and development of drug resistance
- (2010) T. Helleday CARCINOGENESIS
- Polymorphisms of the XRCC3 C722T and the RAD51 G135C genes and the risk of head and neck cancer in a Polish population
- (2010) Tomasz Sliwinski et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Assessment of Genetic Damage in Inflammatory, Precancerous, and Cancerous Pathologies of the Esophagus Using the Comet Assay
- (2010) Mohan Vasavi et al. Genetic Testing and Molecular Biomarkers
- Predictive Effects of ERCC1 and XRCC3 SNP on Efficacy of Platinum-based Chemotherapy in Advanced NSCLC Patients
- (2010) C. Zhou et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Basal levels of DNA damage detected by micronuclei and comet assays in untreated breast cancer patients and healthy women
- (2009) Raquel A. Santos et al. CLINICAL AND EXPERIMENTAL MEDICINE
- Polymorphisms in XRCC1 and XPG and response to platinum-based chemotherapy in advanced non-small cell lung cancer patients
- (2009) Xinchen Sun et al. LUNG CANCER
- Dysfunctional homologous recombination mediates genomic instability and progression in myeloma
- (2008) M. A. Shammas et al. BLOOD
- Association between DNA damage, DNA repair genes variability and clinical characteristics in breast cancer patients
- (2008) Ewelina Synowiec et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started